UC-II · Undenatured Type II Collagen
UC-II is a patented form of undenatured type II collagen extracted from chicken sternum cartilage using a specific low-temperature, non-enzymatic process that preserves the native triple-helix structure of collagen molecules. This is fundamentally different from hydrolyzed collagen peptides (which are denatured into amino acid fragments) - UC-II works via a unique 'oral tolerance' immune mechanism rather than providing collagen building blocks.
Take on empty stomach (morning before food) for optimal Peyer's patch exposure. The triple-helix collagen structure is sensitive to gastric acid, so empty stomach increases delivery to small intestine. Single daily dose - higher doses do NOT help and may reduce effect.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
UC-II works through 'oral tolerance' (also called mucosal tolerance) - a fundamental immune mechanism in which exposure to small amounts of an antigen via the gut trains the systemic immune system not to attack that antigen elsewhere in the body. This is the opposite of vaccination logic.
When undenatured type II collagen is consumed daily in small doses (40mg), it is sampled by M cells overlying Peyer's patches in the small intestine. The collagen is presented to T-regulatory cells (Tregs) in gut-associated lymphoid tissue (GALT). These Tregs then circulate systemically and, when they encounter type II collagen in joint cartilage, they suppress local inflammatory T-cell responses (Th1, Th17) and promote tolerance.
The result is reduced autoimmune attack on joint cartilage, decreased pro-inflammatory cytokine production (TNF-alpha, IL-1, IL-17) at the cartilage interface, and reduced cartilage matrix degradation by MMPs (matrix metalloproteinases).
Critical: this mechanism requires NATIVE (undenatured) collagen with intact triple-helix structure. Hydrolyzed collagen peptides lose the structural epitopes that Tregs recognize, so they cannot trigger oral tolerance. They have different (smaller, building-block) effects.
Critical: dose matters - 40mg/day is the validated therapeutic dose. Higher doses may shift the immune response from tolerance to active recognition (the original mechanism behind some RA studies actually used much higher doses to attempt to provoke immune responses, demonstrating the dose-dependence).
Weeks 1-4: Building immune tolerance, minimal subjective change.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Exact-molecule evidence boundary: the live abstract reports the quoted finding for UC-II Collagen (Undenatured Type II); no broader inference is made.
Undenatured type II collagen (UC-II) is a nutritional supplement derived from chicken sternum cartilage.
Evidence scope. Exact molecule wording appears in the quoted live sentence. Only the population/model, formulation, route, and outcome expressly stated there are supported.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 40mg UC-II; Oral; Once daily. No selected live abstract sentence verified this complete regimen.
Mechanism as written in source JSON. No selected live abstract sentence verified the complete mechanism at the card formulation/route and relevant population/model.
Primary safety claim as written in source JSON. No selected live abstract sentence verified the complete safety claim for this exact formulation and route.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Not applicable in traditional sense - UC-II works locally in gut, not systemically absorbed. Effects are downstream (Treg induction).
Not applicable - oral tolerance effects build over days-weeks, not hours.
Not relevant - UC-II is digested in gut. Tolerance effects (Treg-mediated) persist for weeks after dosing stops.
Not relevant in classical sense. UC-II is intentionally not absorbed - it works at the gut-immune interface (Peyer's patches/M cells).
Tolerance effects build over 60-90 days of daily dosing. Effects persist 4-8+ weeks after stopping (Treg lifespan).
Digested in gut as protein. No systemic clearance considerations.
Storage. Store at room temperature (15-25C) in a cool, dry place. Protect from heat and humidity. Capsules shelf-stable 2+ years.
Classified as a dietary supplement in the US - no prescription required. Widely available. UC-II is a registered trademark of Lonza (formerly InterHealth). No FDA-approved medical indication.
Put it to work
Open UC-II Collagen (Undenatured Type II) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open UC-II Collagen (Undenatured Type II) in the app →Go deeper
The complete UC-II Collagen (Undenatured Type II) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.